Dan Zhang
Vorstandsvorsitzender bei ClinChoice Medical (TIANJIN) Co., Ltd.
Profil
Dan Zhang is the founder of ClinChoice Medical (TIANJIN) Co., Ltd., where he currently holds the title of Chairman, President & Chief Executive Officer.
Dr. Zhang is also the founder of Fountain Medical Development Ltd.
Aktive Positionen von Dan Zhang
Unternehmen | Position | Beginn |
---|---|---|
ClinChoice Medical (TIANJIN) Co., Ltd.
ClinChoice Medical (TIANJIN) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services ClinChoice Medical (TIANJIN) Co., Ltd. operates as a contract research organization. It offers consulting, project management, clinical operations, data reporting and laboratory services. The firm also provides good clinical practice compliant clinical research services for multinational clients. The company was founded by Young Wang, Kaijun Li, Dan Zhang and Joanne Jiang Chen in October 2006 and is headquartered in Beijing, the Republic of China. | Vorstandsvorsitzender | 01.10.2006 |
Fountain Medical Development Ltd.
Fountain Medical Development Ltd. BiotechnologyHealth Technology Part of ClinChoice Medical (TIANJIN) Co., Ltd., Fountain Medical Development Ltd. is a clinical CRO that provides one-stop services for biomedical and medical equipment customers. Clinchoice has been accelerating drug and device approvals to market for more than 25 years and offers services such as project management, clinical operations, biological statistics, data management, registered affairs, medical affairs, and drug warning. The quality service runs through every link of the Clinchoice Kunyu service, and the quality assurance team is an independent team that focuses on the construction and continuous improvement of the American company's internal quality management system. The company was founded by Dan Zhang and Ling Zhen has been the CEO of the company since 2020. Laibiyi was founded in 2016 and is committed to solving the pain points of clinical research through in-depth cooperation with hospitals and a clinical research center that builds standardized standards. In 2021, Clinchoice Kunzhe acquired Laibiyi Technology (Xiamen) Co., Ltd. to further improve its phase I clinical trial platform. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
ClinChoice Medical (TIANJIN) Co., Ltd.
ClinChoice Medical (TIANJIN) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services ClinChoice Medical (TIANJIN) Co., Ltd. operates as a contract research organization. It offers consulting, project management, clinical operations, data reporting and laboratory services. The firm also provides good clinical practice compliant clinical research services for multinational clients. The company was founded by Young Wang, Kaijun Li, Dan Zhang and Joanne Jiang Chen in October 2006 and is headquartered in Beijing, the Republic of China. | Commercial Services |
Fountain Medical Development Ltd.
Fountain Medical Development Ltd. BiotechnologyHealth Technology Part of ClinChoice Medical (TIANJIN) Co., Ltd., Fountain Medical Development Ltd. is a clinical CRO that provides one-stop services for biomedical and medical equipment customers. Clinchoice has been accelerating drug and device approvals to market for more than 25 years and offers services such as project management, clinical operations, biological statistics, data management, registered affairs, medical affairs, and drug warning. The quality service runs through every link of the Clinchoice Kunyu service, and the quality assurance team is an independent team that focuses on the construction and continuous improvement of the American company's internal quality management system. The company was founded by Dan Zhang and Ling Zhen has been the CEO of the company since 2020. Laibiyi was founded in 2016 and is committed to solving the pain points of clinical research through in-depth cooperation with hospitals and a clinical research center that builds standardized standards. In 2021, Clinchoice Kunzhe acquired Laibiyi Technology (Xiamen) Co., Ltd. to further improve its phase I clinical trial platform. | Health Technology |